BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6375067)

  • 1. Natural history and staging of prostate cancer.
    Whitmore WF
    Urol Clin North Am; 1984 May; 11(2):205-20. PubMed ID: 6375067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental carcinoma of the prostate: histopathology and natural history.
    Nemoto R; Harada M; Uchida K; Koiso K; Abe R; Kato T
    Jpn J Clin Oncol; 1985 Dec; 15(4):619-23. PubMed ID: 2419598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphological factors in the prognosis of the treatment results in prostatic cancer].
    Murzaliev AD; Iiazaliev KT; Abdyldaev RA; Sizikov AI
    Urol Nefrol (Mosk); 1996; (1):22-5. PubMed ID: 8659037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of newly diagnosed metastatic carcinoma of the prostate.
    Elder JS; Catalona WJ
    Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the prostate in the elderly.
    Keegan GT; Coffield KS; Singh EO; Kroening PM
    Clin Geriatr Med; 1985 May; 1(2):359-71. PubMed ID: 3830370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: 2. Natural history.
    Nam RK; Jewett MA; Krahn MD
    CMAJ; 1998 Sep; 159(6):685-91. PubMed ID: 9780970
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical staging of prostatic cancer: new modalities.
    Spirnak JP; Resnick MI
    Urol Clin North Am; 1984 May; 11(2):221-35. PubMed ID: 6203203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer in 1994].
    Gil-Vernet JM; Gil-Vernet Sedó JM
    Arch Esp Urol; 1994 May; 47(4):315-35. PubMed ID: 8053718
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
    Cohen SP; Jaskulsky SR
    Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for evaluating patient responses to treatment modalities for prostatic cancer.
    Slack NH; Murphy GP
    Urol Clin North Am; 1984 May; 11(2):337-42. PubMed ID: 6375069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of prostate cancer].
    Auvert J
    Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Suprapubic prostatic sonography for staging prostatic carcinoma].
    Denkhaus H; Dierkopf W; Donn F
    Rofo; 1982 Oct; 137(4):410-6. PubMed ID: 6216177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of stage A1 prostate cancer: the case for treatment.
    Bahnson RR
    Semin Urol; 1993 May; 11(2):54-7. PubMed ID: 7689739
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of imaging procedures in staging prostate cancer. Is CT out?].
    Engelmann U
    Urologe A; 1992 Jul; 31(4):195. PubMed ID: 1514195
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma of the prostate: overview of natural history, staging and treatment.
    Nelson RP
    J S C Med Assoc; 1982 Dec; 78(12):705-9. PubMed ID: 6961256
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic prostate carcinoma].
    Smith MR; Kantoff P; Talcott J
    Praxis (Bern 1994); 2001 Sep; 90(38):1653-8. PubMed ID: 11675919
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
    Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.